Clinical Trial

Evaluate the Safety, Tolerability and Pharmacokinetics of DW5524 in Healthy Adult Volunteers

Not Yet Recruiting Phase 1
View on ClinicalTrials.gov →
Record status
This record was last updated January 20, 2026 (before its estimated February 28, 2026 completion). Its status may not reflect the trial's current state.
Summary
This study aimed to evaluate the safety and pharmacokinetic characteristics of DW5524 in healthy adult volunteers.
Trial Details
NCT Number NCT07349589
Lead Sponsor Daewon Pharmaceutical Co., Ltd.
Conditions Healthy Adult
Enrollment 48 participants
Start Date 2026-02-01
Primary Completion 2026-02-28 (estimated)
Study Completion 2026-12-01 (estimated)
Updated on ClinicalTrials.gov 2026-01-20